Sign In
Buy GDRX
$2.57
-0.0900 (-3.38%)
At Close: Jun 22, 2026
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?
02:10pm, Monday, 18'th Aug 2025
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing, driving a 30% stock surge and validating its business model. Pharma Manufacturer Sol
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
01:11pm, Monday, 18'th Aug 2025
Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the l
Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms
11:26am, Monday, 18'th Aug 2025
Novo Nordisk (NYSE:NVO) shares moved higher on Monday after it was announced that US patients can access its diabetes drug Ozempic at a cheaper price through several platforms, expanding access to th
GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.
09:53am, Monday, 18'th Aug 2025
GoodRx announces a collaboration with Novo Nordisk to make Ozempic cheaper for self-paying patients.
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
09:05am, Monday, 18'th Aug 2025
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozem
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
01:24pm, Friday, 08'th Aug 2025
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director of Investor Relations Christopher A. McGinnis - CFO & Treasurer Wen
Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics
08:31pm, Wednesday, 06'th Aug 2025
The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Lag Estimates
07:46pm, Wednesday, 06'th Aug 2025
GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.
GoodRx Reports Second Quarter 2025 Results
04:05pm, Wednesday, 06'th Aug 2025
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has releas
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
09:00am, Monday, 28'th Jul 2025
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and P
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?
10:31am, Wednesday, 16'th Jul 2025
OPRX is growing faster with rising subscription revenues and strong pharma demand, while GDRX lags due to slower consumer growth.
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
04:05pm, Wednesday, 09'th Jul 2025
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will releas
GDRX vs. HQY: Which Stock Is the Better Value Option?
12:40pm, Wednesday, 09'th Jul 2025
Investors with an interest in Medical Services stocks have likely encountered both GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks is more attractive to value invest
GoodRx: A One Big Beautiful Bill Act Beneficiary
07:36am, Tuesday, 08'th Jul 2025
GoodRx connects uninsured and underinsured consumers with prescription discounts, acting as a broker between consumers, PBMs, and pharmacies. Recent OBBBA legislation will significantly cut Medicaid s
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
09:00am, Tuesday, 10'th Jun 2025
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction
